Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CKD Stage 2”

215 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 215 results

Testing effectiveness (Phase 2)Study completedNCT00434330
What this trial is testing

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 91
Not applicableActive Not RecruitingNCT07348718
What this trial is testing

Rubix LS Diabetic Kidney Disease (DKD) Registry Study

Who this might be right for
Diabetic Kidney Disease (DKD)
Rubix LS 2,000
Large-scale testing (Phase 3)Temporarily pausedNCT05407389
What this trial is testing

Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

Who this might be right for
Chronic Kidney Disease stage4
Kibow Pharma 600
Testing effectiveness (Phase 2)Study completedNCT00527215
What this trial is testing

Phase 2 Study of Darbepoetin Alfa Extended Dosing

Who this might be right for
Pre-Dialysis
Amgen 98
Testing effectiveness (Phase 2)Study completedNCT02895750
What this trial is testing

Efficacity and Safety of Metformin XR in CKD Stage 1 to 3

Who this might be right for
Renal Insufficiency, Chronic
Centre Hospitalier Universitaire, Amiens 12
Large-scale testing (Phase 3)Study completedNCT06706271
What this trial is testing

The Effect of Vitamin D3 Supplementation on Hepcidin and Ferritin Serum Levels in Children With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2
Hasanuddin University 43
Large-scale testing (Phase 3)Study completedNCT02160145
What this trial is testing

Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAutosomal Dominant Polycystic Kidney Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,370
Testing effectiveness (Phase 2)Temporarily pausedNCT04913272
What this trial is testing

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

Who this might be right for
Chronic Kidney Disease stage4
Kibow Pharma 630
Large-scale testing (Phase 3)Study completedNCT05136664
What this trial is testing

Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects

Who this might be right for
HyperkalemiaRenal Insufficiency, Chronic
Vifor Fresenius Medical Care Renal Pharma 262
Large-scale testing (Phase 3)WithdrawnNCT04361552
What this trial is testing

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Who this might be right for
Cerebrovascular AccidentChronic Obstructive Pulmonary DiseaseChronic Renal Failure+4 more
Emory University
Testing effectiveness (Phase 2)Study completedNCT04595370
What this trial is testing

Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease

Who this might be right for
Heart FailureChronic Kidney Disease
AstraZeneca 153
Large-scale testing (Phase 3)Study completedNCT03242252
What this trial is testing

Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 3
Lexicon Pharmaceuticals 787
Testing effectiveness (Phase 2)Active Not RecruitingNCT06942910
What this trial is testing

Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria

Who this might be right for
Chronic Kidney Disease With High Proteinuria
AstraZeneca 224
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Testing effectiveness (Phase 2)Study completedNCT00667576
What this trial is testing

Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis

Who this might be right for
Chronic Kidney Disease on HemodialysisSecondary Hyperparathyroidism
Abbott 153
Not applicableStudy completedNCT06892249
What this trial is testing

Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan

Who this might be right for
CKDLow Protein Dietary IntakeMalnutrition (Calorie)
Fresenius Kabi Taiwan Ltd. 74
Not applicableNot Yet RecruitingNCT07483697
What this trial is testing

Multimodal Intervention for Early Chronic Kidney Disease in Young People: Dysbiosis and Inflammation (CKD)

Who this might be right for
ExerciseDiet InterventionsSymbiotic+3 more
Centenario Hospital Miguel Hidalgo 200
Large-scale testing (Phase 3)Study completedNCT02964936
What this trial is testing

Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia

Who this might be right for
Chronic Kidney Disease
Astellas Pharma Inc 100
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Testing effectiveness (Phase 2)Study completedNCT02260193
What this trial is testing

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Who this might be right for
AnemiaEnd Stage Renal Disease
Akebia Therapeutics 94
Next Page